[ Price : $8.95]
FDA awards U.P. Oncolytics an orphan drug designation for its oncolytic virus-based therapy to treat malignant gliomas.[ Price : $8.95]
FDA says the CDER Office of Prescription Drug Promotion will research how consumers and primary care physicians respond to drug ad...[ Price : $8.95]
FDA commissioner Robert Califf says the agency is being forced by artificial intelligence to rethink how it conducts business.[ Price : $8.95]
FDA warns Orange, CA-based neurologist Namita Goyal about violations found in a bioresearch monitoring inspection of a clinical tr...[ Price : $8.95]
FDA warns Phoenix, AZ-based Amnio Technology it is illegally manufacturing and distributing amniotic membrane and fluid products t...[ Price : $8.95]
Otsuka reports positive topline interim data from an ongoing Phase 3 clinical trial of sibeprenlimab and its use for treating immu...[ Price : $8.95]
FDA sends Camurus a complete response letter on its NDA for CAM2029 (octreotide) extended-release injection and its use in treatin...[ Price : $8.95]
Federal Register notice: FDA extends the comment period for a 9/20 notice on a draft guidance entitled Chemical Analysis for Bioco...